ABSTRACT
This study reports the immunomodulatory activity on human monocyte derived dendritic cells (MDDCs) of a vaccine preparation shown to be effective against an HPV16-related tumour in an animal model. The vaccine is composed of extract from Nicotiana benthamiana leaves containing HPV16 E7 protein expressed by a potato virus X-derived vector (NbPVX-E7). The effect of the extract was evaluated on MDDC differentiation and maturation by monitoring the phenotypic expression of specific markers. The results show that NbPVX-E7 does not induce monocyte differentiation to dendritic cells, but does induce MDDC maturation. Plant extract does not influence MDDC-uptake of E7-FITC while it significantly improves the Ovalbumin-FITC uptake, considered as a model antigen. Importantly, NbPVX-E7-pulsed MDDCs/PBMCs are able to prime human blood-derived lymphocytes from healthy individuals to induce HPV16 E7-specific cytotoxic activity. This is a propaedeutic study for a possible use of E7-containing plant extract in human immunotherapy of HPV-related lesions.
Subject(s)
Adjuvants, Immunologic/pharmacology , Dendritic Cells/immunology , Lymphocytes/immunology , Nicotiana/metabolism , Oncogene Proteins, Viral/immunology , Papillomavirus Vaccines/immunology , Plant Extracts/immunology , Plants, Genetically Modified , Adjuvants, Immunologic/isolation & purification , Antigen Presentation , Cell Differentiation , Cell Line, Tumor , Cell Survival , Coculture Techniques , Cytotoxicity, Immunologic , Dendritic Cells/drug effects , Dendritic Cells/metabolism , Dose-Response Relationship, Drug , Genetic Vectors , Humans , Lymphocyte Activation , Lymphocytes/drug effects , Male , Oncogene Proteins, Viral/biosynthesis , Oncogene Proteins, Viral/genetics , Oncogene Proteins, Viral/isolation & purification , Ovalbumin/immunology , Ovalbumin/metabolism , Papillomavirus E7 Proteins , Papillomavirus Vaccines/biosynthesis , Papillomavirus Vaccines/genetics , Papillomavirus Vaccines/isolation & purification , Plant Extracts/isolation & purification , Plant Leaves , Potexvirus/genetics , Recombinant Proteins/immunology , Time Factors , Nicotiana/geneticsABSTRACT
The human papillomavirus 16 (HPV16) E7 oncoprotein can be considered a "tumor-specific antigen", and therefore it represents a promising target for a therapeutic vaccine against HPV-associated tumors. Efficient production of E7 protein with a plant-based transient expression system has been already described and it was demonstrated that E7-containing crude plant extracts confer partial protection against tumor challenge in a mouse model system. Before adopting the plant-based system as a cost-effective method for the production of an E7-based anti-cancer vaccine, some aspects, such as the oncoprotein yield, need further investigation. In the present study, we report the transient expression, mediated by a potato virus X (PVX)-derived vector, of the E7 protein targeted to the secretory system of Nicotiana benthamiana plants by using a plant-derived signal sequence. Targeting the antigen to the secretory pathway enhanced the E7 protein expression levels about five-fold. Mice immunized by s.c. administration with crude foliar extracts containing E7 showed strong stimulation of cell-mediated immune response after five boosters, as detected by ELISPOT. After challenging with the E7-expressing C3 tumor cells, tumor growth was completely inhibited in 80% of the vaccinated animals and a drastic reduction of tumor burden was observed in the remaining tumor-affected mice. These data demonstrate that, by enhancing E7 yield, it is possible to improve the anti-cancer activity of the plant-based experimental vaccine and open the way for a large-scale production of the E7 protein which could be purified or used as in planta formulation, also suitable for oral therapeutic vaccination.
Subject(s)
Cancer Vaccines/immunology , Cancer Vaccines/pharmacology , Nicotiana/immunology , Oncogene Proteins, Viral/immunology , Papillomaviridae/immunology , Viral Vaccines/immunology , Viral Vaccines/pharmacology , Animals , Antigens, Viral/immunology , Blotting, Western , DNA, Plant/genetics , DNA, Plant/immunology , Enzyme-Linked Immunosorbent Assay , Extracellular Space/metabolism , Female , Immunization , Immunoblotting , Interferon-gamma/metabolism , Mice , Mice, Inbred C57BL , Oncogene Proteins, Viral/genetics , Papillomaviridae/genetics , Papillomavirus E7 Proteins , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocytes/immunology , Nicotiana/chemistryABSTRACT
We report the design, construction and use of an antibody bacteriophage display library built on the scaffold of a single-chain variable fragment (scFv) previously proven to be functionally expressed in the reducing environment of both bacterial and plant cytoplasm and endowed with intrinsic high thermodynamic stability. Four amino acid residues of the third hypervariable loop (CDR3) of both VH and VL were combinatorially mutated, generating a repertoire of approximately 5x10(7) independent scFvs, cloned in a phagemid vector. The ability of the antibody phage library to yield specific binders was tested by biopanning against several antigens. Successful selection of fully active scFvs was obtained, confirming the notion that combinatorial mutagenesis of few amino acid residues centrally located in the antigen-binding site is sufficient to provide binding specificities against virtually any target. High yields of both soluble and phage antibodies were obtained in Escherichia coli. Maintenance of the cognate scFv antibody stability in the newly selected scFv fragments was demonstrated by guanidinium chloride denaturation/renaturation studies and by soluble antibody expression in the bacterial cytoplasm. The antibody library described here allows the isolation of new stable binding specificities, potentially exploitable as immunochemical reagents for intracellular applications.
Subject(s)
Antibody Diversity , Immunoglobulin Fragments/chemistry , Immunoglobulin Fragments/immunology , Peptide Library , Amino Acid Sequence , Animals , Antibody Diversity/genetics , Antibody Diversity/immunology , Antibody Specificity/genetics , Antibody Specificity/immunology , Antigens/immunology , Base Sequence , Binding Sites, Antibody/genetics , Binding Sites, Antibody/immunology , Cloning, Molecular , Complementarity Determining Regions/chemistry , Complementarity Determining Regions/genetics , Complementarity Determining Regions/immunology , Complementarity Determining Regions/metabolism , Cross Reactions/immunology , Cytoplasm/metabolism , Disulfides/metabolism , Enzyme-Linked Immunosorbent Assay , Escherichia coli/cytology , Escherichia coli/genetics , Escherichia coli/metabolism , Guanidine/pharmacology , Immunoglobulin Fragments/genetics , Immunoglobulin Fragments/metabolism , Molecular Sequence Data , Mutagenesis , Oxidation-Reduction , Protein Denaturation/drug effects , Protein Engineering , Protein Renaturation , Solubility , ThermodynamicsABSTRACT
Some aspects of the expression of a single-chain Fv antibody fragment (scFv) driven by the plant viral vector Potato virus X (PVX) have been studied by quantitative ELISA. After inoculation of the infectious transcript, the vector was stable only for a few passages of sap transmission in the inoculated leaves of Nicotiana benthamiana and the reversal to wild type was more pronounced in the systemically invaded leaves. The amount of synthesized scFv varied when different solanaceous hosts were tested, being generally higher and less variable in inoculated than in systemically invaded leaves. In tomato and Datura stramonium the scFv was synthesized only in the inoculated leaves. The scFv was also synthesized in the PVX local hosts Chenopodium amaranticolor and C. quinoa. No correlation was found between PVX and scFv concentration in the inoculated and systemically invaded leaves of N. benthamiana and N. clevelandii.
Subject(s)
Genetic Vectors/genetics , Immunoglobulin Fragments/genetics , Plants/virology , Potexvirus/genetics , Enzyme-Linked Immunosorbent Assay , Immunoglobulin Fragments/biosynthesis , Immunoglobulin G/biosynthesis , Immunoglobulin G/genetics , Plant Diseases/virology , Plant Leaves/virology , Plants, Toxic , Potexvirus/growth & development , Serial Passage , Species Specificity , Nicotiana/virologyABSTRACT
BACKGROUND: Recombinant antibodies expressed in plants ('plantibodies'), directed against crucial antigens and addressed to the right cell compartment, may be able to protect against viral diseases. Moreover, antibody fragments produced in bacteria or plants may provide low cost reagents for immunodiagnosis. OBJECTIVES: In an attempt to develop genetic immunisation against tomato spotted wilt tospovirus (TSWV), we engineered an scFv fragment starting from a monoclonal antibody (mAb) able to recognise an epitope of the glycoprotein G1 conserved among a large number of tospoviruses. After establishing functional expression in bacteria, we aimed to drive expression of this molecule in the secretory pathway of plants. STUDY DESIGN: An antibody phage display expression system was used to isolate the correct VH and VL binding regions from the hybridoma secreting the original mAb. To assess functional expression in plant, we first used an epichromosomal expression vector derived from potato virus X (PVX). In this vector the scFv gene was cloned to produce a cytosolic or a secretory protein. For secretion, the signal sequence derived from the polygalacturonase-inhibiting protein (PGIP) of Phaseolus vulgaris was used. Subsequently, the gene encoding the secretory scFv, was used to transform Nicotiana benthamiana plants. RESULTS: High expression levels of fully active molecule were obtained in Escherichia coli. The engineered molecule retained the binding specificity and dissociation rate constant (k(off)) of the cognate monoclonal antibody. Both PVX-infected and transformed plants expressed fully functional scFv molecules in the secretory pathway. CONCLUSION: This engineered scFv may be valuable for inexpensive diagnosis, for studying the role of the glycoproteins in virus transmission and, possibly, for a 'plantibody'-mediated resistance to tospoviruses.